chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bile output abnormal, Decreased appetite, Fatigue, Illness
Clinical narrative: bile in her urine; could not sleep for two days; could not eat for two days; sick; weak; tired; This spontaneous case was reported by a consumer and describes the occurrence of BILE OUTPUT ABNORMAL (bile in her urine), SLEEP DEFICIT (could not sleep for two days), DECREASED APPETITE (could not eat for two days), ILLNESS (sick) and ASTHENIA (weak) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced BILE OUTPUT ABNORMAL (bile in her urine), SLEEP DEFICIT (could not sleep for two days), DECREASED APPETITE (could not eat for two days), ILLNESS (sick), ASTHENIA (weak) and FATIGUE (tired). At the time of the report, BILE OUTPUT ABNORMAL (bile in her urine), SLEEP DEFICIT (could not sleep for two days), DECREASED APPETITE (could not eat for two days), ILLNESS (sick), ASTHENIA (weak) and FATIGUE (tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep deficit
Clinical narrative: bile in her urine; could not sleep for two days; could not eat for two days; sick; weak; tired; This spontaneous case was reported by a consumer and describes the occurrence of BILE OUTPUT ABNORMAL (bile in her urine), SLEEP DEFICIT (could not sleep for two days), DECREASED APPETITE (could not eat for two days), ILLNESS (sick) and ASTHENIA (weak) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced BILE OUTPUT ABNORMAL (bile in her urine), SLEEP DEFICIT (could not sleep for two days), DECREASED APPETITE (could not eat for two days), ILLNESS (sick), ASTHENIA (weak) and FATIGUE (tired). At the time of the report, BILE OUTPUT ABNORMAL (bile in her urine), SLEEP DEFICIT (could not sleep for two days), DECREASED APPETITE (could not eat for two days), ILLNESS (sick), ASTHENIA (weak) and FATIGUE (tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (Fever) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in August 2020.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever). At the time of the report, CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Mar-2021, Body temperature: inconclusive (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Reporter's email was added. Anatomical location of vaccination and patients medical history were also updated.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pain in extremity
Clinical narrative: sweaty all over body; soreness in arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Mar-2021 and was forwarded to Moderna on 29-Mar-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (soreness in arm) and HYPERHIDROSIS (sweaty all over body) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm). On 17-Mar-2021, the patient experienced HYPERHIDROSIS (sweaty all over body). On 17-Mar-2021, HYPERHIDROSIS (sweaty all over body) had resolved. At the time of the report, PAIN IN EXTREMITY (soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza, Injection site abscess, Injection site warmth, Limb discomfort
Clinical narrative: flu; tired; raised lesion exactly at the site of injection; itchy; arm felt warm; arm felt hard; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (arm felt warm), LIMB DISCOMFORT (arm felt hard), INJECTION SITE ABSCESS (raised lesion exactly at the site of injection), PRURITUS (itchy) and FATIGUE (tired) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026l20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced INJECTION SITE WARMTH (arm felt warm), LIMB DISCOMFORT (arm felt hard), INJECTION SITE ABSCESS (raised lesion exactly at the site of injection) and PRURITUS (itchy). On 05-Feb-2021, the patient experienced FATIGUE (tired) and INFLUENZA (flu). At the time of the report, INJECTION SITE WARMTH (arm felt warm), LIMB DISCOMFORT (arm felt hard), INJECTION SITE ABSCESS (raised lesion exactly at the site of injection), PRURITUS (itchy), FATIGUE (tired) and INFLUENZA (flu) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Patient used topical hydrocortisone on the rash and took zyrtec initially but then switched to benadryl   treatment information provided be reporter was  Patient used topical hydrocortisone on the rash and took zyrtec initially but then switched to benadryl   This case was linked to MODERNATX, INC.-MOD-2021-070135 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-070135:First dose case
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: flu; tired; raised lesion exactly at the site of injection; itchy; arm felt warm; arm felt hard; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (arm felt warm), LIMB DISCOMFORT (arm felt hard), INJECTION SITE ABSCESS (raised lesion exactly at the site of injection), PRURITUS (itchy) and FATIGUE (tired) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026l20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced INJECTION SITE WARMTH (arm felt warm), LIMB DISCOMFORT (arm felt hard), INJECTION SITE ABSCESS (raised lesion exactly at the site of injection) and PRURITUS (itchy). On 05-Feb-2021, the patient experienced FATIGUE (tired) and INFLUENZA (flu). At the time of the report, INJECTION SITE WARMTH (arm felt warm), LIMB DISCOMFORT (arm felt hard), INJECTION SITE ABSCESS (raised lesion exactly at the site of injection), PRURITUS (itchy), FATIGUE (tired) and INFLUENZA (flu) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Patient used topical hydrocortisone on the rash and took zyrtec initially but then switched to benadryl   treatment information provided be reporter was  Patient used topical hydrocortisone on the rash and took zyrtec initially but then switched to benadryl   This case was linked to MODERNATX, INC.-MOD-2021-070135 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-070135:First dose case
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Shoulder soreness; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Shoulder soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced ARTHRALGIA (Shoulder soreness). At the time of the report, ARTHRALGIA (Shoulder soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-062329, MOD-2021-062340 (E2B Linked Report).; Sender's Comments:  MOD-2021-062329: MOD-2021-062340:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis, Urticaria
Clinical narrative: Hives over entire body; muffled hearing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives over entire body) and HYPOACUSIS (muffled hearing) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016MZ0A and 032M20A) for COVID-19 vaccination.     Concomitant products included VALSARTAN, RIVAROXABAN (XARELTO), CARVEDILOL, METFORMIN, ALOPURINOL, SEMAGLUTIDE (OZEMPIC), EVOLOCUMAB (REPATHA) and COLCHICINE for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced URTICARIA (Hives over entire body) and HYPOACUSIS (muffled hearing). At the time of the report, URTICARIA (Hives over entire body) and HYPOACUSIS (muffled hearing) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient went to emergency department due to symptoms. Treatment information was provided as Antibiotic, Steroid Shot in Knee, diphenhydramine hydrochloride Cream, Prednisone Cream.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Pain in extremity, Product dose omission issue
Clinical narrative: missed her appointment for the second dose; Right leg hurts; trouble walking; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Right leg hurts), GAIT DISTURBANCE (trouble walking) and PRODUCT DOSE OMISSION ISSUE (missed her appointment for the second dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included Back surgery.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Right leg hurts) and GAIT DISTURBANCE (trouble walking). On 22-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed her appointment for the second dose). On 22-Feb-2021, PRODUCT DOSE OMISSION ISSUE (missed her appointment for the second dose) had resolved. At the time of the report, PAIN IN EXTREMITY (Right leg hurts) and GAIT DISTURBANCE (trouble walking) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. Before receiving the vaccine patient was perfectly fine, but after some weeks her right leg started hurting and was in a lot of pain. patient had trouble walking and missed her appointment for the second dose on 22 Feb 2021. Patient went to emergency room (ER) where she received Z-Pack and a muscle relaxer, though it didn't help much. She's able to walk now, but leg still doesn't feel right.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Maternal exposure during pregnancy, Myalgia
Clinical narrative: Maternal exposure during pregnancy; Severe body ache; Fatigue; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy), MYALGIA (Severe body ache) and FATIGUE (Fatigue) in an adult female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 01-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy), MYALGIA (Severe body ache) and FATIGUE (Fatigue). On 01-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. At the time of the report, MYALGIA (Severe body ache) and FATIGUE (Fatigue) outcome was unknown.            Treatment, Concomitant product  information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Reporter details updated
Sex: F
Vaccine: COVID19
Symptoms: Illness, Infection
Clinical narrative: become sick; very bad infection on left side of jaw; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (become sick) and INFECTION (very bad infection on left side of jaw) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (become sick) and INFECTION (very bad infection on left side of jaw). At the time of the report, ILLNESS (become sick) and INFECTION (very bad infection on left side of jaw) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Depressed mood, Fatigue, Headache, Insomnia, Pain in extremity
Clinical narrative: feels desperate; tired; fatigued; didn't sleep well.; a bit of a headache; felt restless; Pain in arm; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), RESTLESSNESS (felt restless), DEPRESSED MOOD (feels desperate), INSOMNIA (didn't sleep well.) and HEADACHE (a bit of a headache) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included FENOFIBRATE for Cholesterol, FLUOXETINE HCL and TRAZODONE for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 29-Mar-2021, the patient experienced RESTLESSNESS (felt restless), INSOMNIA (didn't sleep well.) and HEADACHE (a bit of a headache). On 30-Mar-2021, the patient experienced DEPRESSED MOOD (feels desperate), FATIGUE (tired) and FATIGUE (fatigued). On 28-Mar-2021, PAIN IN EXTREMITY (Pain in arm) had resolved. At the time of the report, RESTLESSNESS (felt restless), DEPRESSED MOOD (feels desperate), INSOMNIA (didn't sleep well.), HEADACHE (a bit of a headache), FATIGUE (tired) and FATIGUE (fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Treatment details provided include Advil double action: acetaminophen and ibuprofen,echinacea,aswagandha
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Restlessness
Clinical narrative: feels desperate; tired; fatigued; didn't sleep well.; a bit of a headache; felt restless; Pain in arm; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), RESTLESSNESS (felt restless), DEPRESSED MOOD (feels desperate), INSOMNIA (didn't sleep well.) and HEADACHE (a bit of a headache) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included FENOFIBRATE for Cholesterol, FLUOXETINE HCL and TRAZODONE for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 29-Mar-2021, the patient experienced RESTLESSNESS (felt restless), INSOMNIA (didn't sleep well.) and HEADACHE (a bit of a headache). On 30-Mar-2021, the patient experienced DEPRESSED MOOD (feels desperate), FATIGUE (tired) and FATIGUE (fatigued). On 28-Mar-2021, PAIN IN EXTREMITY (Pain in arm) had resolved. At the time of the report, RESTLESSNESS (felt restless), DEPRESSED MOOD (feels desperate), INSOMNIA (didn't sleep well.), HEADACHE (a bit of a headache), FATIGUE (tired) and FATIGUE (fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Treatment details provided include Advil double action: acetaminophen and ibuprofen,echinacea,aswagandha
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: hurting in the first few days; Red dot on the injection area; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red dot on the injection area) and INJECTION SITE PAIN (hurting in the first few days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Red dot on the injection area). On an unknown date, the patient experienced INJECTION SITE PAIN (hurting in the first few days). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE ERYTHEMA (Red dot on the injection area) and INJECTION SITE PAIN (hurting in the first few days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications include Blood thinners and Diabetic medication.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Skin warm, Vaccination complication
Clinical narrative: felt fine yesterday,started experiencing side effects,the side effects come and go; left arm is "very warm"; dizziness,lightheadedness; fatigue; feels terrible; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt fine yesterday,started experiencing side effects,the side effects come and go), SKIN WARM (left arm is "very warm"), DIZZINESS (dizziness,lightheadedness), FEELING ABNORMAL (feels terrible) and FATIGUE (fatigue) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced FEELING ABNORMAL (feels terrible). On an unknown date, the patient experienced VACCINATION COMPLICATION (felt fine yesterday,started experiencing side effects,the side effects come and go), SKIN WARM (left arm is "very warm"), DIZZINESS (dizziness,lightheadedness) and FATIGUE (fatigue). At the time of the report, VACCINATION COMPLICATION (felt fine yesterday,started experiencing side effects,the side effects come and go), SKIN WARM (left arm is "very warm"), DIZZINESS (dizziness,lightheadedness), FEELING ABNORMAL (feels terrible) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       VACCINATION COMPLICATION (felt fine yesterday, started experiencing side effects,t he side effects come and go.  felt fine yesterday was on 30/Mar/2021.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Psychotic disorder
Clinical narrative: Psychotic break down; Became very depressed; This spontaneous case was reported by a consumer and describes the occurrence of PSYCHOTIC DISORDER (Psychotic break down) and DEPRESSION (Became very depressed) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PSYCHOTIC DISORDER (Psychotic break down) and DEPRESSION (Became very depressed). At the time of the report, PSYCHOTIC DISORDER (Psychotic break down) and DEPRESSION (Became very depressed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment medications was reported.   This case was linked to MOD-2021-064043 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: NNI On 03-Jul-2021: Followup received and reporter information was added.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information is not expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Dizziness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and HEADACHE (headaches) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (Dizziness) and HEADACHE (headaches). At the time of the report, DIZZINESS (Dizziness) outcome was unknown and HEADACHE (headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Limb discomfort
Clinical narrative: light tiredness; tiredness in the legs only after his second dose; heaviness in the legs; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (light tiredness), FATIGUE (tiredness in the legs only after his second dose) and LIMB DISCOMFORT (heaviness in the legs) in a male patient of an unknown age who received mRNA-1273 (COVID-19 Vaccine Moderna) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (COVID-19 Vaccine Moderna) (unknown route) .5 dosage form. On an unknown date, the patient experienced FATIGUE (light tiredness), FATIGUE (tiredness in the legs only after his second dose) and LIMB DISCOMFORT (heaviness in the legs). At the time of the report, FATIGUE (light tiredness), FATIGUE (tiredness in the legs only after his second dose) and LIMB DISCOMFORT (heaviness in the legs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (COVID-19 Vaccine Moderna) (Unknown) was unknown.       No concomitant and treatment medications were reported.   This case was linked to MOD-2021-064063.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Visual impairment
Clinical narrative: fatigue; her arm was very sore; get a little flash of white light on left eye of peripheral vision; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (her arm was very sore) and VISUAL IMPAIRMENT (get a little flash of white light on left eye of peripheral vision) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), BUPROPION, MULTIVITAMINS [VITAMINS NOS], ESTRADIOL and PROGESTERONE for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue), MYALGIA (her arm was very sore) and VISUAL IMPAIRMENT (get a little flash of white light on left eye of peripheral vision). At the time of the report, FATIGUE (fatigue), MYALGIA (her arm was very sore) and VISUAL IMPAIRMENT (get a little flash of white light on left eye of peripheral vision) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were reported.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Ultrasound scan
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 44-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Alcoholism (1 glass of wine a day) in 1995. Concurrent medical conditions included Mental disorder (It is improving) since 1998. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy, LEVOTHYROXINE for Thyroid disorder.    On 08-Mar-2021 at 11:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 06-Dec-2020 and the estimated date of delivery was 12-Sep-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: felt like there was something stuck in my throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (felt like there was something stuck in my throat) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced THROAT IRRITATION (felt like there was something stuck in my throat). On 04-Mar-2021, THROAT IRRITATION (felt like there was something stuck in my throat) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was unknown
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: rash on middle section of her body like hives; This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (rash on middle section of her body like hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (rash on middle section of her body like hives). At the time of the report, URTICARIA (rash on middle section of her body like hives) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Cough, Headache, Nausea
Clinical narrative: body aches; coughing; loss of tatse and smell; Loss of taste and smell; nauseated; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), COUGH (coughing), AGEUSIA (loss of tatse and smell), ANOSMIA (Loss of taste and smell) and NAUSEA (nauseated) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), COUGH (coughing), AGEUSIA (loss of tatse and smell), ANOSMIA (Loss of taste and smell), NAUSEA (nauseated) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), COUGH (coughing), AGEUSIA (loss of tatse and smell), ANOSMIA (Loss of taste and smell), NAUSEA (nauseated) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: body aches; coughing; loss of tatse and smell; Loss of taste and smell; nauseated; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), COUGH (coughing), AGEUSIA (loss of tatse and smell), ANOSMIA (Loss of taste and smell) and NAUSEA (nauseated) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), COUGH (coughing), AGEUSIA (loss of tatse and smell), ANOSMIA (Loss of taste and smell), NAUSEA (nauseated) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), COUGH (coughing), AGEUSIA (loss of tatse and smell), ANOSMIA (Loss of taste and smell), NAUSEA (nauseated) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, COVID-19, Chills, Hyperhidrosis, Insomnia
Clinical narrative: COVID-19 like symptoms; Chills; Body aches; Heavy Perspiration; Extremely thirsty; Cannot sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), HYPERHIDROSIS (Heavy Perspiration), INSOMNIA (Cannot sleep), THIRST (Extremely thirsty) and COVID-19 (COVID-19 like symptoms) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (COVID-19 positive). Concomitant products included TESTOSTERONE (ANDROGEL) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced INSOMNIA (Cannot sleep). On 27-Mar-2021, the patient experienced PAIN (Body aches), HYPERHIDROSIS (Heavy Perspiration), THIRST (Extremely thirsty) and CHILLS (Chills). On an unknown date, the patient experienced COVID-19 (COVID-19 like symptoms). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 27-Mar-2021, INSOMNIA (Cannot sleep) had resolved. On 29-Mar-2021, PAIN (Body aches), HYPERHIDROSIS (Heavy Perspiration), THIRST (Extremely thirsty) and CHILLS (Chills) had resolved. At the time of the report, COVID-19 (COVID-19 like symptoms) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test (other-Unknown): had IgM and IgG antibodies.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information include androgen Treatment information included Tylenol .
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Thirst
Clinical narrative: COVID-19 like symptoms; Chills; Body aches; Heavy Perspiration; Extremely thirsty; Cannot sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), HYPERHIDROSIS (Heavy Perspiration), INSOMNIA (Cannot sleep), THIRST (Extremely thirsty) and COVID-19 (COVID-19 like symptoms) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (COVID-19 positive). Concomitant products included TESTOSTERONE (ANDROGEL) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced INSOMNIA (Cannot sleep). On 27-Mar-2021, the patient experienced PAIN (Body aches), HYPERHIDROSIS (Heavy Perspiration), THIRST (Extremely thirsty) and CHILLS (Chills). On an unknown date, the patient experienced COVID-19 (COVID-19 like symptoms). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 27-Mar-2021, INSOMNIA (Cannot sleep) had resolved. On 29-Mar-2021, PAIN (Body aches), HYPERHIDROSIS (Heavy Perspiration), THIRST (Extremely thirsty) and CHILLS (Chills) had resolved. At the time of the report, COVID-19 (COVID-19 like symptoms) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test (other-Unknown): had IgM and IgG antibodies.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information include androgen Treatment information included Tylenol .
Sex: U
Vaccine: COVID19
Symptoms: Eating disorder, Oral blood blister, Pain, Swollen tongue, Tongue discolouration
Clinical narrative: blood blisters in my mouth; swollen white tongue; swollen white tongue; difficult to eat; there is pain; This spontaneous case was reported by a consumer and describes the occurrence of ORAL BLOOD BLISTER (blood blisters in my mouth), SWOLLEN TONGUE (swollen white tongue), TONGUE DISCOLOURATION (swollen white tongue), EATING DISORDER (difficult to eat) and PAIN (there is pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ORAL BLOOD BLISTER (blood blisters in my mouth), SWOLLEN TONGUE (swollen white tongue), TONGUE DISCOLOURATION (swollen white tongue), EATING DISORDER (difficult to eat) and PAIN (there is pain).            This case was linked to MOD-2021-024310 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: NNI.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Eating disorder, Nausea
Clinical narrative: Couldn't eat nor drink anything; Nauseous for a period of 8-10 hours; This spontaneous case was reported by a consumer and describes the occurrence of EATING DISORDER (Couldn't eat nor drink anything) and NAUSEA (Nauseous for a period of 8-10 hours) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced EATING DISORDER (Couldn't eat nor drink anything) and NAUSEA (Nauseous for a period of 8-10 hours). On 17-Mar-2021, EATING DISORDER (Couldn't eat nor drink anything) and NAUSEA (Nauseous for a period of 8-10 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on the arm where she received the vaccine; This spontaneous case was reported by a physician and describes the occurrence of RASH (rash on the arm where she received the vaccine) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced RASH (rash on the arm where she received the vaccine). On 16-Mar-2021, RASH (rash on the arm where she received the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: similar symptoms (of COVID); I have a Covid, result came yesterday; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I have a Covid, result came yesterday) and COVID-19 (similar symptoms (of COVID)) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced COVID-19 (I have a Covid, result came yesterday). On an unknown date, the patient experienced COVID-19 (similar symptoms (of COVID)). At the time of the report, COVID-19 (I have a Covid, result came yesterday) and COVID-19 (similar symptoms (of COVID)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications medication were reported. No treatment medications were reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Erythema, Facial pain, Fatigue
Clinical narrative: Pain at the injection site/Tenderness at the injection site (left arm); muscle pain; joint pain; headaches; migraine; neck pain "like snapping a rubber band"; a pain in the face nerve like "bell palsy" which caused a brief 20 second paralysis but was not a bell palsy; a redness on the muscle area/a red line around the arm; Swelling; fatigue; chills; Feels a very nasty taste when is gargling and brushing the teeth.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site/Tenderness at the injection site (left arm)), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headaches) and MIGRAINE (migraine) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site/Tenderness at the injection site (left arm)), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headaches), MIGRAINE (migraine), NECK PAIN (neck pain "like snapping a rubber band"), FACIAL PAIN (a pain in the face nerve like "bell palsy" which caused a brief 20 second paralysis but was not a bell palsy), ERYTHEMA (a redness on the muscle area/a red line around the arm), SWELLING (Swelling), FATIGUE (fatigue), CHILLS (chills) and TASTE DISORDER (Feels a very nasty taste when is gargling and brushing the teeth.). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site/Tenderness at the injection site (left arm)), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headaches), MIGRAINE (migraine), NECK PAIN (neck pain "like snapping a rubber band"), FACIAL PAIN (a pain in the face nerve like "bell palsy" which caused a brief 20 second paralysis but was not a bell palsy), ERYTHEMA (a redness on the muscle area/a red line around the arm), SWELLING (Swelling), FATIGUE (fatigue), CHILLS (chills) and TASTE DISORDER (Feels a very nasty taste when is gargling and brushing the teeth.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and Treatment medications were not provided by reporter.